Answers are grounded in this paper and cite their sources.
Incretin-based pharmacotherapy — glucagon-like peptide-1 (GLP-1) receptor agonists, dual GIP/GLP-1 co-agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors — has reshaped the treatment of type 2 diabetes and obesity since 2005. Exercise acts on many of the same endocrine, metabolic and immune targets, yet the interface between exercise-responsive biology and incretin drug targets has never been mapped quantitatively. We conducted a dual-database bibliometric and knowledge-mapping analysis of Web of Science Core Collection and Scopus records (2005–2026) to describe (i) the collaboration structure of the field by author, institution and country; (ii) its intellectual base through document co-citation clustering; and (iii) its emerging fronts through keyword burst detection. Four thousand two hundred sixty unique articles were retained after screening and three-step deduplication. The co-citation network (3,203 nodes; 11,124 edges; modularity Q = 0.9358; weighted mean silhouette S = 0.9508) resolves into 18 clusters that consolidate into six mechanistically coherent thematic domains: exercise-responsive molecular and metabolic targets, pharmacological targets and exercise mimetics, multi-omics target discovery, exerkine secretion dynamics, drug–exercise interactions, and epigenetic–pancreatic endocrine targets. Eight keyword bursts consolidate into three emerging trends: outcome-oriented epidemiology, renal and haemodynamic endpoint validation, and lifestyle-integrated combination care. This registration freezes the search strings, inclusion and exclusion criteria, deduplication algorithm, entity-normalisation rules and analysis parameters; the analysis scripts are deposited with the registration. Registration type: Open-Ended Registration. Bibliographic data were retrieved on 10 October 2026 and the analyses were completed before this registration was submitted; the registration documents the research questions, data pipeline and analysis plan as implemented, and no analytic decision was modified after results were observed.
No takes yet. Share an insight, caveat, or question.
Liang Shuai (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: